{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:22:06Z","timestamp":1790637726195,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM104537"],"award-info":[{"award-number":["P20GM104537"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL151407"],"award-info":[{"award-number":["R01HL151407"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["F31HL149257"],"award-info":[{"award-number":["F31HL149257"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["P01HL51971"],"award-info":[{"award-number":["P01HL51971"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R00HL130456"],"award-info":[{"award-number":["R00HL130456"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK109133"],"award-info":[{"award-number":["R01DK109133"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.preghy.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T12:11:09Z","timestamp":1620994269000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Tumor Necrosis Factor-alpha Blockade Improves Uterine Artery Resistance, Maternal Blood Pressure, and Fetal Growth in Placental Ischemic Rats"],"prefix":"10.1016","volume":"25","author":[{"given":"Olivia K.","family":"Travis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geilda A.","family":"Tardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Giachelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Siddiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison T.","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise C.","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.preghy.2021.05.002_b0005","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/nure.12055","article-title":"Epidemiology of preeclampsia: impact of obesity","volume":"71","author":"Jeyabalan","year":"2013","journal-title":"Nutr. Rev."},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0146-0005(00)80050-6","article-title":"Preeclampsia: what we know and what we do not know","volume":"24","author":"Roberts","year":"2000","journal-title":"Semin. Perinatol."},{"issue":"3","key":"10.1016\/j.preghy.2021.05.002_b0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2215\/CJN.03761106","article-title":"Pathophysiology of the clinical manifestations of preeclampsia","volume":"2","author":"Hladunewich","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.preghy.2021.05.002_b0020","first-page":"467","article-title":"Pre-eclampsia: pathophysiology, diagnosis, and management","volume":"7","author":"Uzan","year":"2011","journal-title":"Vasc. Health Risk Manag"},{"key":"10.1016\/j.preghy.2021.05.002_b0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","article-title":"Pathogenesis of preeclampsia","volume":"5","author":"Young","year":"2010","journal-title":"Annu. Rev. Pathol."},{"issue":"14","key":"10.1016\/j.preghy.2021.05.002_b0030","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","article-title":"Preeclampsia-pathophysiology and clinical presentations","volume":"76","author":"Ives Christopher","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.preghy.2021.05.002_b0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1600-0897.2012.01120.x","article-title":"Changes of NK cells in preeclampsia","volume":"67","author":"Fukui","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jri.2011.04.006","article-title":"Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia","volume":"90","author":"Fukui","year":"2011","journal-title":"J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41467-017-00269-1","article-title":"Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia","volume":"8","author":"Yougbare","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.preghy.2021.05.002_b0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.mam.2007.02.006","article-title":"The role of the immune system in preeclampsia","volume":"28","author":"Saito","year":"2007","journal-title":"Mol. Aspects Med."},{"issue":"Suppl 2","key":"10.1016\/j.preghy.2021.05.002_b0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.enfcli.2019.07.021","article-title":"Tumour necrosis factor-alpha (TNF-alpha) serum levels in preeclampsia pregnant women and pregnant women at risk with preeclampsia","volume":"30","author":"Trisnawati","year":"2020","journal-title":"Enferm. Clin."},{"key":"10.1016\/j.preghy.2021.05.002_b0060","first-page":"219","article-title":"The role of cytokines as inflammatory mediators in preeclampsia","volume":"20","author":"Udenze","year":"2015","journal-title":"Pan Afr. Med. J."},{"issue":"2","key":"10.1016\/j.preghy.2021.05.002_b0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000369363","article-title":"Tumor necrosis factor-alpha and pregnancy complications: a prospective study","volume":"24","author":"Azizieh","year":"2015","journal-title":"Med. Princ. Pract."},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-016-8596-x","article-title":"Tumor necrosis factor-alpha and pregnancy: Focus on Biologics An Updated and Comprehensive Review","volume":"53","author":"Alijotas-Reig","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.preghy.2021.05.002_b0075","doi-asserted-by":"crossref","unstructured":"D.C. Cornelius, Preeclampsia: From Inflammation to Immunoregulation, Clin Med Insights Blood Disord 11 (2018) 1179545X17752325.","DOI":"10.1177\/1179545X17752325"},{"issue":"Suppl 1","key":"10.1016\/j.preghy.2021.05.002_b0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000354200","article-title":"Cytokines as key players in the pathophysiology of preeclampsia","volume":"22","author":"Raghupathy","year":"2013","journal-title":"Med. Princ. Pract."},{"issue":"4","key":"10.1016\/j.preghy.2021.05.002_b0085","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.HYP.0000175476.26719.36","article-title":"Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha","volume":"46","author":"LaMarca","year":"2005","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.preghy.2021.05.002_b0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cyto.2011.06.003","article-title":"Tumor necrosis factor alpha induces a model of preeclampsia in pregnant baboons (Papio hamadryas)","volume":"56","author":"Sunderland","year":"2011","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.preghy.2021.05.002_b0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/CS20080196","article-title":"Role of TNF-alpha in vascular dysfunction","volume":"116","author":"Zhang","year":"2009","journal-title":"Clin. Sci. (Lond)"},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000229685.37402.80","article-title":"Tumor Necrosis Factor-\u03b1 induces endothelial dysfunction in the prediabetic metabolic syndrome","volume":"99","author":"Picchi","year":"2006","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.preghy.2021.05.002_b0105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/HYPERTENSIONAHA.109.132191","article-title":"Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization","volume":"54","author":"Walsh","year":"2009","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0110","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00117.2012","article-title":"A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model","volume":"303","author":"Li","year":"2012","journal-title":"Am. J. Physiol. Heart Circ Physiol."},{"key":"10.1016\/j.preghy.2021.05.002_b0115","article-title":"Adoptive transfer of placental ischemia-stimulated natural killer cells causes a preeclampsia-like phenotype in pregnant rats","author":"Travis","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"issue":"23","key":"10.1016\/j.preghy.2021.05.002_b0120","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1042\/CS20171118","article-title":"Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure","volume":"131","author":"Elfarra","year":"2017","journal-title":"Clin. Sci. (Lond)"},{"issue":"6","key":"10.1016\/j.preghy.2021.05.002_b0125","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/HYPERTENSIONAHA.117.09969","article-title":"Continued investigation Into 17-OHPC: Results from the preclinical RUPP rat model of preeclampsia","volume":"70","author":"Amaral","year":"2017","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.preghy.2021.05.002_b0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10641955.2020.1793999","article-title":"Tumor necrosis factor alpha (TNF-alpha) blockade improves natural killer cell (NK) activation, hypertension, and mitochondrial oxidative stress in a preclinical rat model of preeclampsia","volume":"39","author":"Cunningham","year":"2020","journal-title":"Hypertens Pregnancy"},{"issue":"6","key":"10.1016\/j.preghy.2021.05.002_b0135","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/HYPERTENSIONAHA.108.120881","article-title":"Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: Effect of tumor necrosis factor-alpha blockade","volume":"52","author":"LaMarca","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.05.002_b0140","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00285.2019","article-title":"Interleukin-17 signaling mediates cytolytic natural killer cell activation in response to placental ischemia","author":"Travis","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"2","key":"10.1016\/j.preghy.2021.05.002_b0145","doi-asserted-by":"crossref","first-page":"R336","DOI":"10.1152\/ajpregu.00061.2018","article-title":"Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy","volume":"315","author":"Shields","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.preghy.2021.05.002_b0150","doi-asserted-by":"crossref","first-page":"R1192","DOI":"10.1152\/ajpregu.00117.2016","article-title":"Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy","volume":"311","author":"Cornelius","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.114.04484","article-title":"17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model","volume":"65","author":"Amaral","year":"2015","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.preghy.2021.05.002_b0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1189\/jlb.0611308","article-title":"Natural killer cell-produced IFN-gamma and TNF-alpha induce target cell cytolysis through up-regulation of ICAM-1","volume":"91","author":"Wang","year":"2012","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF01540972","article-title":"Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation","volume":"16","author":"Jewett","year":"1996","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.preghy.2021.05.002_b0170","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1152\/ajpregu.00069.2012","article-title":"Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia\/hypoxia: Role of tumor necrosis factor-alpha","volume":"304","author":"Murphy","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.preghy.2021.05.002_b0175","first-page":"515","article-title":"Diagnostic evaluation of uterine artery Doppler sonography for the prediction of adverse pregnancy outcomes","volume":"19","author":"Barati","year":"2014","journal-title":"J. Res. Med. Sci."},{"issue":"6","key":"10.1016\/j.preghy.2021.05.002_b0180","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1503\/cmaj.070430","article-title":"Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis","volume":"178","author":"Cnossen","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.preghy.2021.05.002_b0185","doi-asserted-by":"crossref","unstructured":"Z. Alfirevic, T. Stampalija, T. Dowswell, Fetal and umbilical Doppler ultrasound in high-risk pregnancies, Cochrane Database Syst Rev 6 (2017) CD007529.","DOI":"10.1002\/14651858.CD007529.pub4"},{"key":"10.1016\/j.preghy.2021.05.002_b0190","doi-asserted-by":"crossref","first-page":"14805","DOI":"10.1038\/ncomms14805","article-title":"Constitutive smooth muscle tumour necrosis factor regulates microvascular myogenic responsiveness and systemic blood pressure","volume":"8","author":"Kroetsch","year":"2017","journal-title":"Nat. Commun."},{"issue":"12 Suppl 4","key":"10.1016\/j.preghy.2021.05.002_b0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1524-6175.2006.06032.x","article-title":"Nitric oxide in hypertension","volume":"8","author":"Hermann","year":"2006","journal-title":"J. Clin. Hypertens (Greenwich)"},{"issue":"7","key":"10.1016\/j.preghy.2021.05.002_b0200","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/ars.2007.1959","article-title":"Nitric oxide in the vasculature: Where does it come from and where does it go? A quantitative perspective","volume":"10","author":"Chen","year":"2008","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"10.1016\/j.preghy.2021.05.002_b0205","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0002-9378(94)70064-8","article-title":"The role of nitric oxide in the pathogenesis of preeclampsia","volume":"171","author":"Seligman","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2021.05.002_b0210","first-page":"257","article-title":"Nitric oxide production increases during normal pregnancy and decreases in preeclampsia","volume":"32","author":"Choi","year":"2002","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"4","key":"10.1016\/j.preghy.2021.05.002_b0215","first-page":"227","article-title":"Nitric oxide as a unique bioactive signaling messenger in physiology and pathophysiology","volume":"2004","author":"Tuteja","year":"2004","journal-title":"J. Biomed. Biotechnol."},{"issue":"10","key":"10.1016\/j.preghy.2021.05.002_b0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11906-017-0774-6","article-title":"Altered endothelial nitric oxide signaling as a paradigm for maternal vascular maladaptation in preeclampsia","volume":"19","author":"Osol","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.preghy.2021.05.002_b0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.niox.2019.11.006","article-title":"Nitric oxide signaling in pregnancy and preeclampsia","volume":"95","author":"Sutton","year":"2020","journal-title":"Nitric Oxide"},{"issue":"6","key":"10.1016\/j.preghy.2021.05.002_b0230","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11906-003-0057-2","article-title":"Pathophysiology of pre-eclampsia: Update on the role of nitric oxide","volume":"5","author":"Kashiwagi","year":"2003","journal-title":"Curr. Hypertens. Rep."},{"issue":"5","key":"10.1016\/j.preghy.2021.05.002_b0235","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/0002-9378(93)90299-X","article-title":"Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia","volume":"169","author":"Yallampalli","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2 Pt 1","key":"10.1016\/j.preghy.2021.05.002_b0240","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0895-7061(01)02255-5","article-title":"Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression","volume":"15","author":"Alexander","year":"2002","journal-title":"Am. J. Hypertens."},{"issue":"5","key":"10.1016\/j.preghy.2021.05.002_b0245","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0029-1211368","article-title":"Atrial natriuretic peptide (ANP) in preeclampsia-like syndrome in a rat model","volume":"103","author":"Casper","year":"1995","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"10","key":"10.1016\/j.preghy.2021.05.002_b0250","doi-asserted-by":"crossref","first-page":"F1047","DOI":"10.1152\/ajprenal.00164.2014","article-title":"ANP-induced signaling cascade and its implications in renal pathophysiology","volume":"308","author":"Theilig","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"5","key":"10.1016\/j.preghy.2021.05.002_b0255","first-page":"1095","article-title":"Increases in plasma atrial natriuretic peptide concentration antedate clinical evidence of preeclampsia","volume":"74","author":"Malee","year":"1992","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.preghy.2021.05.002_b0260","unstructured":"B. Adam, Malatyalio, gbreve, E. lu, M. Alvur, A. K\u00f6k\u00e7\u00fc, A. Bedir, Plasma Atrial Natriuretic Peptide Levels in Preeclampsia and Eclampsia, J Matern Fetal Investig 8(2) (1998) 85-8."},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0265","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.preghy.2021.05.002_b0270","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/hr.2011.39","article-title":"Oxidative stress and endothelial dysfunction in hypertension","volume":"34","author":"Schulz","year":"2011","journal-title":"Hypertens. Res."},{"issue":"3","key":"10.1016\/j.preghy.2021.05.002_b0275","first-page":"142","article-title":"The effects of nitric oxide donors on uterine artery and sub-endometrial blood flow in patients with unexplained recurrent abortion","volume":"15","author":"Abdel-Razik","year":"2014","journal-title":"J. Reprod. Infertil."},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/HYPERTENSIONAHA.111.187559","article-title":"Endothelial nitric oxide synthase deficiency reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant mice","volume":"60","author":"Kulandavelu","year":"2012","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.preghy.2021.05.002_b0285","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1210\/jc.2009-0945","article-title":"Preeclampsia and soluble fms-like tyrosine kinase 1","volume":"94","author":"Roberts","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.preghy.2021.05.002_b0290","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.preghy.2021.05.002_b0295","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ceb.2012.02.002","article-title":"VEGF signaling inside vascular endothelial cells and beyond","volume":"24","author":"Eichmann","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"issue":"22","key":"10.1016\/j.preghy.2021.05.002_b0300","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.preghy.2021.05.002_b0305","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.preghy.2021.05.002_b0310","doi-asserted-by":"crossref","first-page":"R505","DOI":"10.1152\/ajpregu.00137.2016","article-title":"Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy","volume":"311","author":"Zhu","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.preghy.2021.05.002_b0315","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/HYPERTENSIONAHA.107.096594","article-title":"Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression","volume":"50","author":"Gilbert","year":"2007","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.preghy.2021.05.002_b0320","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ajh.2009.24","article-title":"Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats","volume":"22","author":"Bridges","year":"2009","journal-title":"Am. J. Hypertens."},{"issue":"2","key":"10.1016\/j.preghy.2021.05.002_b0325","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/HYPERTENSIONAHA.109.141473","article-title":"Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats","volume":"55","author":"Murphy","year":"2010","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0330","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-7-16","article-title":"Mechanisms of tumor necrosis factor-\u03b1-induced interleukin-6 synthesis in glioma cells","volume":"7","author":"Tanabe","year":"2010","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.preghy.2021.05.002_b0335","first-page":"17","article-title":"Regulation of TNF-alpha-induced IL-6 production in MG-63 human osteoblast-like cells","volume":"81","author":"Webb","year":"2002","journal-title":"J. Dent. Res."},{"issue":"2","key":"10.1016\/j.preghy.2021.05.002_b0340","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0897.1998.tb00398.x","article-title":"Circulating levels of immunoreactive cytokines in women with preeclampsia","volume":"40","author":"Conrad","year":"1998","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.preghy.2021.05.002_b0345","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cyto.2012.07.039","article-title":"The increased maternal serum levels of IL-6 are associated with the severity and onset of preeclampsia","volume":"60","author":"Xiao","year":"2012","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.preghy.2021.05.002_b0350","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/01.HYP.0000238442.33463.94","article-title":"Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6","volume":"48","author":"Gadonski","year":"2006","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.preghy.2021.05.002_b0355","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1161\/ATVBAHA.107.153080","article-title":"IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy","volume":"27","author":"Schrader","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.preghy.2021.05.002_b0360","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/HJH.0b013e32833992ef","article-title":"Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells","volume":"28","author":"Hung","year":"2010","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.preghy.2021.05.002_b0365","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/IJICMR.S22329","article-title":"Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation","volume":"2011","author":"Lamarca","year":"2011","journal-title":"Int. J. Interferon Cytokine Mediat. Res."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:57:15Z","timestamp":1761897435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778921000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":73,"alternative-id":["S2210778921000337"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2021.05.002","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor Necrosis Factor-alpha Blockade Improves Uterine Artery Resistance, Maternal Blood Pressure, and Fetal Growth in Placental Ischemic Rats","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}